UNICREDIT BANK/CALL/BIOGEN IDEC/250/0.1/18.12.24 Share Price

Warrant

DE000HD0BKQ0

Real-time BOERSE MUENCHEN 03:10:09 02/07/2024 pm IST
1.52 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/250/0.1/18.12.24
Current month+5.56%
1 month+1.33%
Date Price Change
02/24/02 1.52 0.00%
01/24/01 1.52 +5.56%
28/24/28 1.44 +0.70%
27/24/27 1.43 +16.26%
26/24/26 1.23 -0.81%

Real-time BOERSE MUENCHEN

Last update July 02, 2024 at 03:10 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD0BKQ
ISINDE000HD0BKQ0
Date issued 31/10/2023
Strike 250 $
Maturity 18/12/2024 (170 Days)
Parity 10 : 1
Emission price 3.62
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 4.7
Lowest since issue 0.69
Delta0.46x
Omega 6.623
Premium14.75x
Gearing14.52x
Moneyness 0.9271
Difference Strike 18.23 $
Difference Strike %+7.29%
Spread 0.06
Spread %3.95%
Theoretical value 1.490
Implied Volatility 33.29 %
Total Loss Probability 63.17 %
Intrinsic value 0.000000
Present value 1.490
Break even 265.96 €
Theta-0.05x
Vega0.06x
Rho0.04x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
231.8 USD
Average target price
283.2 USD
Spread / Average Target
+22.17%
Consensus